Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Fusions of the SYT and SSX genes in synovial sarcoma

Abstract

Synovial sarcomas are high grade spindle cell tumors that are divided into two major histologic subtypes, biphasic and monophasic, according to the respective presence or absence of a well-developed glandular epithelial component. They contain in essentially all cases a t(X;18) representing the fusion of SYT (at 18q11) with either SSX1 or SSX2 (both at Xp11). Neither SYT, nor the SSX proteins contain DNA-binding domains. Instead, they appear to be transcriptional regulators whose actions are mediated primarily through protein-protein interactions, with BRM in the case of SYT, and with Polycomb group repressors in the case of SSX. Ongoing work on the SYT–SSX fusion and synovial sarcoma should yield a variety of data of broader biological interest, in areas such as BRM and Polycomb group function and dysfunction, transcriptional targets of SYT–SSX proteins and their native counterparts, differential gene regulation by SYT–SSX1 and SYT–SSX2, control of glandular morphogenesis, among others.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Allander SV, Chen Y, Illei PB, Antonescu CR, Ladanyi M, Meltzer PS . 2001 Proc. Am. Assoc. Cancer Res. 42: 430

  • Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M . 2000 Diagn. Mol. Pathol. 9: 1–8

  • Barr FG . 1998 Nat. Genet. 19: 121–124

  • Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, Tora L . 1998 Mol. Cell Biol. 18: 1489–1497

  • Birdsall S, Osin P, Lu YJ, Fisher C, Shipley J . 1999 Int. J. Cancer 82: 605–608

  • Bouffler S, Silver A, Cox R . 1993 Bioessays 15: 409–412

  • Brett D, Whitehouse S, Per A, Shipley J, Cooper C, Goodwin G . 1997 Hum. Mol. Genet. 6: 1559–1564

  • Castagnino P, Lorenzi MV, Yeh J, Breckenridge D, Sakata H, Munz B, Werner S, Bottaro DP . 2000 Oncogene 19: 640–648

  • Chand A, Clark J, Cooper CS, Craig IW . 1995 Genomics 30: 545–552

  • Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC . 1997 Oncogene 14: 1617–1622

  • Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, Gusterson BA, Cooper CS . 1994 Nature Genet. 7: 502–508

  • Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS . 1995 EMBO J. 14: 2333–2340

  • de Alava E, Kawai A, Healey JH, Fligman I, Meyers P, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PHB, Barr FG, Ladanyi M . 1998 J. Clin. Oncol. 16: 1248–1255

  • de Bruijn DR, Baats E, Zechner U, De Leeuw B, Balemans M, Olde Weghuis D, Hirning-Folz U, Geurts van Kessel A . 1996 Oncogene 13: 643–648

  • De Leeuw B, Balemans M, Geurts van Kessel A . 1996 Cytogenet. Cell Genet. 73: 179–183

  • De Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A . 1995 Hum. Mol. Genet. 4: 1097–1099

  • De Leeuw B, Suijkerbuijk RF, Olde Weghuis D, Meloni AM, Stenman G, Kindblom LG, Balemans M, van den Berg E, Molenaar WM, Sandberg AA, Geurts van Kessel A . 1994 Cancer Genet. Cytogenet. 73: 89–94

  • dos Santos NR, de Bruijn DR, Kater-Baats E, Otte AP, Geurts van Kessel A . 2000 Exp. Cell Res. 256: 192–202

  • dos Santos NR, de Bruijn DR, Guerts van Kessel A . 2001 Genes Chromosom. Cancer 30: 1–14

  • dos Santos NR, de Bruijn DRH, Balemans M, Janssen B, Gartner F, Lopes JM, De Leeuw B, van Kessel AG . 1997 Hum. Mol. Genet. 6: 1549–1558

  • Eid JE, Kung AL, Scully R, Livingston DM . 2000 Cell 102: 839–848

  • Frisch SM . 1997 Bioessays 19: 705–709

  • Geurts van Kessel AG, dos Santos NR, Simons A, de Bruijn D, Forus A, Fodstad O, Myklebost O, Balemans M, Baats E, Weghuis DO, Suijkerbuijk RF, van den Berg E, Molenaar WM, De Leeuw B . 1997 Cancer Genet. Cytogenet. 95: 67–73

  • Guillou L, Coindre J, Gallagher G, Terrier P, Gebhard S, de Saint A, Michels J, Jundt G, Vince DR, Collin F, Trassard M, Le Doussal V, Benhattar J . 2001 Hum. Pathol. 32: 105–112

  • Gure AO, Tureci O, Sahin U, Tsang S, Scanlan MJ, Jager E, Knuth A, Pfreundschuh M, Old LJ, Chen YT . 1997 Int. J. Cancer 72: 965–971

  • Hashimoto N, Araki N, Yoshikawa H, Myoui A, Matsumine A, Kaneko M, Sonobe H, Ochi T . 2000 Cancer Lett. 149: 31–36

  • Hiraga H, Nojima T, Abe S, Sawa H, Yamashiro K, Yamawaki S, Kaneda K, Nagashima K . 1998 Diag. Mol. Pathol. 7: 102–110

  • Illei PB, Allander SV, Chen Y, Meltzer PS, Antonescu CR, Ladanyi M . 2001 Mod. Pathol. 14: 13A

  • Inagaki H, Murase T, Otsuka T, Eimoto T . 1999 Am. J. Clin. Pathol. 111: 528–533

  • Janz M, De Leeuw B, Olde Weghuis D, Werner M, Nolte M, Geurts van Kessel A, Nordheim A, Hipskind RA . 1995 J. Pathol. 175: 391–396

  • Kas K, Finger E, Grall F, Gu X, Akbarali Y, Boltax J, Weiss A, Oettgen P, Kapeller R, Libermann TA . 2000 J. Biol. Chem. 275: 2986–2998

  • Kasai T, Shimajiri S, Hashimoto H . 2000 Mol. Pathol. 53: 107–110

  • Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M . 1998 New Engl. J. Med. 338: 153–160

  • Kelly KM, Womer RB, Sorensen PHB, Xiong Q-B, Barr FG . 1997 J. Clin. Oncol. 15: 1831–1836

  • Kuhnen C, Tolnay E, Steinau HU, Voss B, Muller KM . 1998 Virchows Arch. 432: 337–342

  • Ladanyi M, Bridge JA . 2000 Hum. Pathol. 31: 532–538

  • Lee SB, Kolquist KA, Nichols K, Engler C, Shyamala M, Ladanyi M, Gerald WL, Haber DA . 1997 Nature Genet. 17: 309–313

  • Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, Brennan MF . 2000 J. Clin. Oncol. 18: 2087–2094

  • Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC . 1998 Oncogene 17: 2013–2018

  • Lin PP, Brody RI, Hamelin A, Bradner JE, Healey JH, Ladanyi M . 1999 Cancer Res. 59: 1428–1432

  • Mancuso T, Mezzelani A, Riva C, Fabbri A, Dal Bo L, Sampietro G, Perego P, Casali P, Zunino F, Sozzi G, Pierotti MA, Pilotti S . 2000 Lab. Invest. 80: 805–813

  • Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher FJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4509–4513

  • Miller AP, Gustashaw K, Wolff DJ, Rider SH, Monaco AP, Eble B, Schlessinger D, Gorski JL, van Ommen GJ, Weissenbach J, Willard HF . 1995 Hum. Mol. Genet. 4: 731–739

  • Nagai M, Tanaka S, Tsuda M, Endo S, Kato H, Sonobe H, Minami A, Hiraga H, Nishihara H, Sawa H, NAgashima K. . 2001 Proc. Natl. Acad. Sci. U.S.A. 98: 3843–3848

  • Nielsen TO, Brown PO, Botstein D, van de Rijn M . 2001 Mod. Pathol. 14: 16A

  • Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhlen M, Larsson O . 1999 Cancer Res. 59: 3180–3184

  • Oda Y, Sakamoto A, Saito T, Kinukawa N, Iwamoto Y, Tsuneyoshi M . 2000 Hum. Pathol. 31: 185–192

  • Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K, Libermann TA . 1997 Mol. Cell Biol. 17: 4419–4433

  • Petermann R, Mossier B, Aryee D, Khazak V, Golemis E, Kovar H . 1998 Oncogene 17: 603–610

  • Renwick PJ, Reeves BR, Dal Cin P, Fletcher CD, Kempski H, Sciot R, Kazmierczak B, Jani K, Sonobe H, Knight JC . 1995 Cytogenet. Cell Genet. 70: 58–63

  • Shipley J, Crew J, Birdsall S, Gill S, Clark J, Fisher C, Kelsey A, Nojima T, Sonobe H, Cooper C, Gusterson B . 1996 Am. J. Pathol. 148: 559–567

  • Shipley JM, Clark J, Crew AJ, Birdsall S, Rocques PJ, Gill S, Chelly J, Monaco AP, Abe S, Gusterson BA, Cooper CS . 1994 Oncogene 9: 1447–1453

  • Skytting B, Nilsson G, Brodin B, Xie YT, Lundeberg J, Uhlen M, Larsson O . 1999 J. Natl. Cancer Inst. 91: 974–975

  • Sonobe H, Takeuchi T, Liag SB, Taguchi T, Yuri K, Shimizu K, Iwata J, Furihata M, Ohtsuki Y, Testa JR . 1999 Int. J. Cancer 82: 459–464

  • Soulez M, Saurin AJ, Freemont PS, Knight JC . 1999 Oncogene 18: 2739–2746

  • Thaete C, Brett D, Monaghan P, Whitehouse S, Rennie G, Rayner E, Cooper CS, Goodwin G . 1999 Hum. Mol. Genet. 8: 585–591

  • Tsarfaty I, Rong S, Resau JH, Rulong S, da Silva PP, Vande Woude GF . 1994 Science 263: 98–101

  • Tureci O, Chen YT, Sahin U, Gure AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, Pfreundschuh M . 1998 Int. J. Cancer 77: 19–23

  • Tureci O, Sahin U, Schobert I, Koslowski M, Scmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M . 1996 Cancer Res. 56: 4766–4772

  • van de Rijn M, Barr FG, Collins MH, Xiong Q-B, Fisher C . 1999 Am. J. Clin. Pathol. 112: 43–49

  • Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV . 1994 Proc. Natl. Acad. Sci. USA 91: 4514–4518

  • Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W . 1995 J. Cell Biol. 131: 215–226

  • Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, Smith TL, Jurgens H, Gadner H, Kovar H . 1996 J. Clin. Oncol. 14: 1245–1251

Download references

Acknowledgements

ML is supported by grant PO1 CA47179 from the National Institute of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc Ladanyi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ladanyi, M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 20, 5755–5762 (2001). https://doi.org/10.1038/sj.onc.1204601

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204601

Keywords

This article is cited by

Search

Quick links